Delivery Order SPE2DB20D2104-SPE2DB25FMBPF

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,591.92 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The award is not associated with a set-aside program. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,896.22 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has an ultimate completion date of March 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,684.96 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of May 12, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $17,355.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML syringes, a specialty medication, with an ultimate completion date of December 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,561.86, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of November 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,684.96 Firm Fixed Price Delivery Order is for the supply of 4566767380 STELARA 45 MG/0.5 ML SYRINGE 0.5ML, with a performance period ending on December 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,343.24, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract is a firm fixed-price Delivery Order with a completion date of September 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,460.12 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGE syringes. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,476.38 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGE/ML, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,707.25, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period extending to January 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMBPF
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,506.87 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order, with an ultimate completion date of October 30, 2024, is one of many contract awards held by AmerisourceBergen with various federal agencies, demonstrating the company's role as a critical vendor for the government's medical supply needs.

Generated 2/27/25, 12:47 PM